2023年度论文（SCI收录）
1. You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, Zhuang W, Li L, Tao Y. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023 May 10;8(1):196. (IF: 39.3)（陶永光组）
2. Long Y, Guo J, Chen J, Sun J, Wang H, Peng X, Wang Z, Lai W, Liu N, Shu L, Chen L, Shi Y, Xiao D, Liu S, Tao Y. GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer. Signal Transduct Target Ther. 2023 Feb 1;8(1):48. (IF: 39.3)（陶永光组）
3. Tang J, Wang X, Xiao D, Liu S, Tao Y. The chromatin - associated RNAs in gene regulation and cancer. Mol Cancer. 2023 Feb 7;22(1):27. (IF: 37.3)（陶永光组）
4. Yang M, Mo Y, Ren D, Liu S, Zeng Z, Xiong W. Transfer RNA - derived small RNAs in tumor microenvironment. Mol Cancer. 2023 Feb 16;22(1):32. (IF: 37.3)（曾朝阳/熊炜组）
5. Lai W, Hu W, Liang Y, Yang L, Mao C, Tao T, Wang X, Xiao D, Liu S, Tao Y. New mouse genetic model of breast cancer from IKKa defects in dendritic cells revealed by single-cell RNA sequencing. Cell Discovery. 2023 Jul 18;9(1):72. (IF: 33.5)（陶永光组）
6. Youwen Y, Changfu L, Lida S, Zhenyu Z, Shuping P*, Cijun S*. In-situ deposition of apatite layer to protect Mg-based composite fabricated via laser additive manufacturing. Journal of Magnesium and Alloy. 2023, 11(2): 629 - 640. (IF: 17.6)（彭淑平组）
7. Kuang C, Xia M, An G, Liu C, Hu C, Zhang J, Liu Z, Meng B, Su P, Xia J, Guo J, Zhu Y, Liu X, Wu X, Shen Y, Feng X, He Y, Li J, Qiu L, Zhou J, Zhou W. Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma. Nat Commun. 2023 Apr 13;14(1):2093. (IF: 16.6)（周文组）
8. Yang R, Peng W, Shi S, Peng X, Cai Q, Zhao Z, He B, Tu G, Yin W, Chen Y, Zhang Y, Liu F, Wang X, Xiao D, Tao Y. The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma. Adv Sci (Weinh). 2023 Sep;10(25):e2300971. (IF: 15.1)（陶永光组）
9. Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, Zhou L, Tao Y. Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Adv Sci (Weinh). 2023 Nov;10(33):e2302953. (IF: 15.100)（陶永光组）
10. Wang Q, Zhi Y, Zi M, Mo Y, Wang Y, Liao Q, Zhang S, Gong Z, Wang F, Zeng Z, Guo C, Xiong W. Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. Adv Sci (Weinh). 2023 Oct;10(30):e2302558. (IF: 15.1)（熊炜组）
11. Deng K, Zhang LL, Gao W, Lin X, Long XM, Wang Y, Wu MH. A functional carbon dots induce ferroptosis by suppressing PLPP4 activity to inhibit glioblastoma growth. Chemical Engineering Journal. 2023,475:146473. (IF: 15.1)（武明花组）
12. Tang J, Yang Q, Mao C, Xiao D, Liu S, Xiao L, Zhou L, Wu G, Tao Y. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway. Cell Death Differ. 2023 May;30(5):1247 - 1259. (IF: 12.4)（陶永光组）
13. Wu P, Hou X, Peng M, Deng X, Yan Q, Fan C, Mo Y, Wang Y, Li Z, Wang F, Guo C, Zhou M, Liao Q, Wang H, Zeng Z, Jiang W, Li G, Xiong W, Xiang B. Circular RNA circRILPL1 promotes nasopharyngeal carcinoma malignant progression by activating the Hippo-YAP signaling pathway. Cell Death Differ. 2023 Jul;30(7):1679 - 1694. (IF: 12.4)（向波组）
14. Chen Y, Ouyang Y, Li Z, Wang X, Ma J. S100A8 and S100A9 in Cancer. Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188891. (IF: 11.414)（马健组）
15. Wei J, Li M, Xue C, Chen S, Zheng L, Deng H, Tang F, Li G, Xiong W, Zeng Z, Zhou M. Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. J Exp Clin Cancer Res. 2023 Apr 15;42(1):86. (IF: 11.3)（周鸣组）
16. Liao C, Li M, Chen X, Tang C, Quan J, Bode AM, Cao Y, Luo X. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2023 Oct 7;42(1):261. (IF: 11.300)（罗湘建组）
17. Li T, Zeng Z, Fan C, Xiong W. Role of stress granules in tumorigenesis and cancer therapy. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189006. (IF: 11.2)（熊炜组）
18. Liu Q, Bode AM, Chen X, Luo X. Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189023. (IF: 11.200)（罗湘建组）
19. Chen L, Cai Q, Yang R, Wang H, Ling H, Li T, Liu N, Wang Z, Sun J, Tao T, Shi Y, Cao Y, Wang X, Xiao D, Liu S, Tao Y. GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail. Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2219585120. (IF: 11.1)（陶永光组）
20. Li S, Liu H, Liu W, Shi N, Zhao M, Wanggou S, Luo W, Wang L, Zhu B, Zuo X, Xie W, Zhao C, Zhou Y, Luo L, Gao X, Jiang X, Ren C. ESRG is critical to maintain the cell survival and self-renewal/pluripotency of hPSCs by collaborating with MCM2 to suppress p53 pathway. Int J Biol Sci. 2023 Jan 16;19(3):916 - 935. (IF: 10.750)（任彩萍组）
21. Liu S, Liao S, Liang L, Deng J, Zhou Y. The relationship between CD4+T cell glycolysis and their functions. Trends Endocrinol Metab. 2023 Jun;34(6):345 - 360. (IF: 10.586)（周艳宏组）
22. Chen M, Yang Y, Tang L, He S, Guo W, Ge G, Zeng Z, Li X, Li G, Xiong W, Wu SX. Iron-Rich Semiconducting Polymer Dots for the Combination of Ferroptosis-Starvation and Phototherapeutic Cancer Therapy. Advanced Healthcare Materials. 2023 Oct;12(26):e2300839. (IF: 10)（熊炜组）
23. Yan B, Guo J, Wang Z, Ning J, Wang H, Shu L, Hu K, Chen L, Shi Y, Zhang L, Liu S, Tao Y, Xiao D. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression. Med Comm(2020). 2023 Jul 22;4(4):e337. (IF: 9.9)（陶永光组）
24. Chen Y, Liu Y, Xiong J, Ouyang L, Tang M, Mao C, Li L, Xiao D, Liu S, Yang Z, Huang J, Tao Y. LINC02774 inhibits glycolysis in glioma to destabilize HIF-1α dependent on transcription factor RP58. Med Comm(2020). 2023 Sep 11;4(5):e364. (IF: 9.900)（陶永光组）
25. Cijun S, Shiwei Z, Yang S, Wenjing Y, Shuping P, Chongxian H. Accelerated anode and cathode reaction due to direct electron uptake and consumption by manganese dioxide and titanium dioxide composite cathode in degradation of iron composite. Journal of Colloid and Interface Science. 2023 Feb 15;632(Pt A):95 - 107. (IF: 9.9)（彭淑平组）
26. Jiang Z, Zhou J, Li L, Liao S, He J, Zhou S, Zhou Y. Pericytes in the tumor microenvironment. Cancer Letters. 2023 Mar 1;556(0):216074. (IF: 9.756)（周艳宏组）
27. Liu Z, Wang D, Zhang J, Xiang P, Zeng Z, Xiong W, Shi L. cGAS - STING signaling in the tumor microenvironment. Cancer Letters. 2023 Nov 28;577:216409. (IF: 9.756)（熊炜组）
28. Ren D, Mo Y, Yang M, Wang D, Wang Y, Yan Q, Guo C, Xiong W, Wang F, Zeng Z. Emerging roles of tRNA in cancer. Cancer Letters. 2023 Jun 1;563:216170. (IF: 9.756)（曾朝阳组）
29. Zhou R, Chen S, Wu Q, Liu L, Wang Y, Mo Y, Zeng Z, Zu X, Xiong W, Wang F*. CD155 and its receptors in cancer immune escape and immunotherapy. Cancer Letters. 2023 Oct 1;573:216381. (IF: 9.756)（熊炜组）
30. Li M, Wang Y, Wu P, Zhang S, Gong Z, Liao Q, Guo C, Wang F, Li Y, Zeng Z, Yan Q, Xiong W*. Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy. Cancer Letters. 2023 Jun 1;563:216190. (IF: 9.756)（熊炜组）
31. Wang Y, Yan Q, Fan C, Mo Y, Wang Y, Li X, Liao Q, Guo C, Li G, Zeng Z, Xiong W, Huang H. Overview and countermeasures of cancer burden in China. Science China Life Sciences. 2023 Nov;66(11):2515-2526. (IF: 9.1)（熊炜组）
32. Li M, Wei Y, Liu Y, Wei J, Zhou X, Duan Y, Chen S, Xue C, Zhan Y, Zheng L, Deng H, Tang F, Fan S, Xiong W, Li G, Tan M, Zhou M. BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma. Cell Death Dis. 2023 Feb 14;14(2):121. (IF: 9)（周鸣组）
33. Cao J, Liao S, Zeng F, Liao Q, Luo G, Zhou Y*. Effects of altered glycolysis levels on CD8 + T cell activation and function. Cell Death Dis. 2023 Jul 8;14(7):407. (IF: 9)（周艳宏组）
34. Tang Q, Li L, Wang Y, Wu P, Hou X, Ouyang J, Fan C, Li Z, Wang F, Guo C, Zhou M, Liao Q, Wang H, Xiang B, Jiang W, Li G, Zeng Z, Xiong W*. RNA modifications in cancer. British Journal of Cancer. 2023 Aug;129(2):204 - 221. (IF: 8.8)（曾朝阳/熊炜组）
35. Huang C, Deng K, Wu M*. Mitochondrial cristae in health and disease. Int J Biol Macromol. 2023 Apr 30;235:123755. (IF: 8.2)（武明花组）
36. Yang Liu, Gang Xu, Haijuan Fu, Peiyao Li, Danyang Li, Kun Deng, Wei Gao, Yujie Shang, Minghua Wu*. Membrane - bound transcription factor LRRC4 inhibits glioblastoma cell motility. Int J Biol Macromol. 2023 Aug 15:246:125590. (IF: 8.2)（武明花组）
37. Wang Z, Ouyang L, Liu N, Li T, Yan B, Mao C, Xiao D, Gan B, Liu S, Tao Y. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis. Oncogene. 2023 Sep;42(36):2688 - 2700. (IF: 8)（陶永光组）
38. Li W, Gao M, Hu C, Chen X, Zhou Y. NMNAT2: An important metabolic enzyme affecting the disease progression. Biomed Pharmacother. 2023 Feb:158:114143. (IF: 7.419)（周艳宏组）
39. Liu Y, Wu M*. Deep learning in precision medicine and focus on glioma. Bioeng Transl Med. 2023 May 31;8(5):e10553. (IF: 7.4)（武明花组）
40. Du G, Xing Z, Zhou J, Cui C, Liu C, Liu Y, Li Z*. Retinoic Acid - Inducible Gene - I like receptor Pathway in Cancer: Modification and Treatment. Frontiers in Immunology. 2023 Aug 16;14:1227041. (IF: 7.3)（李征组）
41. Zhou Y, Yin W, Kuang Y, Wu Z, Huang H, Liu W, Jiang X, Ren C*. A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients. Front Immunol. 2023 Nov 1;14:1138363. (IF: 7.300)（任彩萍组）
42. Guo Y, Jiang Z, Chen Q, Xie D, Zhou Y, Yin W, Wang Z, Wang B, Ren C, Jiang X*. Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs. Front Immunol. 2023 Nov 3;14:1291385. (IF: 7.300)（任彩萍组）
43. Zhou Y, Cao Y, Liu W, Wang L, Kuang Y, Zhou Y, Chen Q, Cheng Z, Huang H, Zhang W, Jiang X, Wang B, Ren C*. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma. Front Immunol. 2023 Dec 15;14:1294459. (IF: 7.300)（任彩萍组）
44. Fangwei Qi, Ruobing Liao, Ping Wu, Huixing Li, Jun Zan, Shuping Peng, Cijun Shuai*. An electrical microenvironment constructed based on electromagnetic induction stimulates neural differentiation. Materials Chemistry Frontiers. 2023, doi: 10.1039/d2qm01193j. (IF: 7)（彭淑平组）
45. Guowen Qian, Lemin Zhang, Yang Shuai, Xiongting Wu, Zhikui Zeng, Shuping Peng, Cijun Shuai*. 3D-printed CuFe2O4 -MXene/PLLA antibacterial tracheal scaffold against implantation-associated infection. Applied Surface Science. 2023, doi: 10.1016/j.apsusc.2022.156108. (IF: 6.7)（彭淑平组）
46. Qi F, Li H, Gao X, Wang Y, Qian H, Li W, Liu S, Zhou H, Peng S, Shuai C*. Oxygen vacancy healing boosts the piezoelectricity of bone scaffolds. Biomaterials Science. 2024 Jan 16;12(2):495- 506. (IF: 6.6)（彭淑平组）
47. Tian J, Ma J*. The Value of Microbes in Cancer Neoantigen Immunotherapy. Pharmaceutics. 2023 Aug 14;15(8):2138. (IF: 6.525)（马健组）
48. Zhang J, Shi F, Liu X, Wu X, Hu C, Guo J, Yang Q, Xia J, He Y, An G, Qiu L, Feng X, Zhou W*. Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenase. Br J Haematol. 2023 May;201(4):704 - 717. (IF: 6.5)（周文组）
49. Fangwei Qi, Huixing Li, Gang Chen, Shuping Peng, Cijun Shua*. An oxygen self-supplied CuO2@g-C3N4 heterojunction endows photodynamic antibacterial performance of scaffold. Journal of Alloys and Compounds. 2023, doi: 10.1016/j.jallcom.2023.171526. (IF: 6.2)（彭淑平组）
50. Zhang X, Zheng R, Li Z, Ma J*. Liquid - liquid Phase Separation in Viral Function. Journal of Molecular Biology. 2023 Aug 15;435(16):167955. (IF: 6.151)（马健组）
51. Zhang Z, Peng Y, Peng X, Xiao D, Shi Y, Tao Y*. Effects of radiation therapy on tumor microenvironment: an updated review. Chin Med J (Engl). 2023 Dec 5;136(23):2802 - 2811. (IF: 6.1)（陶永光组）
52. Deng K, Wu M*. Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma. Chin Med J. 2023 Jan 5;136(1):4 - 12. (IF: 6.1)（武明花组）
53. Wang L, Yin N, Shi W, Xie Y, Yi J, Tang Z, Tang J, Xiang J*. Splicing inhibition mediated by reduced splicing factors and helicases is associated with the cellular response of lung cancer cells to cisplatin. Comput Struct Biotechnol J. 2023 Dec 28;23:648-658. (IF: 6)（向娟娟组）
54. Fangwei Qi, Xiaosong Chen, Huixing Li, Gang Chen, Xinrui Luo, Shiyu Xiong, Shuping Peng, and Cijun Shuai*. Photoelectric Bi2S3 Nanoparticle/Ti3C2Tx Nanosheet Heterojunction for Promotion of Nerve Cell Growth. ACS Applied Nano Materials. 2023, doi: 10.1021/acsanm.3c01795. (IF: 5.9)（彭淑平组）
55. Shuai C, Chen X, He C, Chen M, Peng S, Yang W*. Fe-doped mesoporous silica catalyzes ascorbic acid oxidation for tumor - specific therapy in scaffold. Colloids and Surfaces B: Biointerfaces. 2023 May;225:113251. (IF: 5.8)（彭淑平组）
56. Xu H, Yin Y, Li Y, Shi N, Xie W, Luo W, Wang L, Zhu B, Liu W, Jiang X, Ren C*. Flot2 promotes nasopharyngeal carcinoma progression through suppression of TGF-β pathway via facilitating CD109 expression. iScience. 2023 Nov 25;27(1):108580. (IF: 5.800)（任彩萍组）
57. He C, Zeng X, Yang L, Zhong S, Peng S, Yang W, Shuai C*. Highly Dispersed Cu Produced by Mechanical Stress-Activated Redox Reaction to Establish Galvanic Corrosion in Fe Implant. ACS materials Science & Engineering. 2023 Jan 9;9(1):153 - 164. (IF: 5.7)（彭淑平组）
58. Li M, Duan Y, Wei J, Chen S, Xue C, Zheng L, Deng H, Fan S, Xiong W, Li G, Tan M, Tang F, She K, Zhou M*. Yin Yang 1 suppresses tumor invasion and metastasis in nasopharyngeal carcinoma by negatively regulating eIF4E transcriptional activity and expression. Am J Cancer Res. 2023 Aug 15;13(8):3763 - 3780. (IF: 5.3)（周鸣组）
59. Zhu Y, Yang Q, Yang Q, He Y, Zhou W*. Intestinal Microbes and Hematological Malignancies. Cancers (Basel). 2023 Apr 13;15(8):2284. (IF: 5.2)（周文组）
60. Yang Q, Wei Y, Zhu Y, Guo J, Zhang J, He Y, Li X, Liu J, Zhou W*. The Interaction between Gut Microbiota and Host Amino Acids Metabolism in Multiple Myeloma. Cancers (Basel). 2023 Mar 23;15(7):1942. (IF: 5.2)（周文组）
61. C Ren, Q Zhou, S Li, XJ Yan, H Zhu, WD Liu, Y Guo, HJ Xu, W Yin, X Li*. Characterization, potential prognostic value, and immune heterogeneity of cathepsin C in diffuse glioma. Current Bioinformatics. 2023, doi:10.2174/1574893618666221101144857. (IF: 4.850)（任彩萍组）
62. Peng S, He T, Liu Y, Zheng L, Zhong Y, Niu Z, Zhang M, Yang S*. Lnc - PPP2R1B Mediates the Alternative Splicing of PPP2R1B by Interacting and Stabilizing HNRNPLL and Promotes Osteogenesis of MSCs. Stem Cell Rev Rep. 2023 Aug;19(6):1981 - 1993. (IF: 4.8)（彭淑平组）
63. Wu Y, Zhang X, Liu C, Li Z, Wen Y, Zheng R, Xu C, Tian J, Wei L, Wang J, Yan Q, Zheng X, Ma J*. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1. Journal of Biological Chemistry. 2023 Sep;299(9):105082. (IF: 4.800)（马健组）
64. Wu Z, Li W, Zhu H, Li X, Zhou Y, Chen Q, Huang H, Zhang W, Jiang X, Ren C*. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma. Front genet. 2023 Mar 1;14:1124439. (IF: 4.772)（任彩萍组）
65. Liu Y, Ouyang L, Mao C, Chen Y, Liu N, Chen L, Shi Y, Xiao D, Liu S, Tao Y*. Inhibition of RNF182 mediated by Bap promotes non - small cell lung cancer progression. Front Oncol. 2023 Jan 6;12:1009508. (IF: 4.7)（陶永光组）
66. Zheng L, Duan Y, Li M, Wei J, Xue C, Chen S, Wei Q, Tang F, Xiong W, Zhou M, Deng H*. Deciphering the vital roles and mechanism of m5C modification on RNA in cancers. Am J Cancer Res. 2023 Dec 15;13(12):6125 - 6146. (IF: 4.7)（周鸣组）
67. Li M, Wei J, Xue C, Zhou X, Chen S, Zheng L, Duan Y, Deng H, Xiong W, Tang F, Li G, Zhou M*. Dissecting the roles and clinical potential of YY1 in the tumor microenvironment. Front Oncol. 2023 Apr 4;13:1122110. (IF: 4.7)（周鸣组）
68. Guo W, Chen M, Yang Y, Ge G, Tang L, He S, Zeng Z, Li X, Li G, Xiong W, Wu S*. Biocompatibility and Biological Effects of Surface - Modified Conjugated Polymer Nanoparticles. Molecules. 2023 Feb 21;28(5):2034. (IF: 4.6)（熊炜组）
69. Guowen Qian, Junzhe Wang, Liuyimei Yang, Zhikui Zeng, Zhenyu Zhao, Shuping Peng*, Cijun Shuai*. A Ph-Responsive Cao2@Zif-67 System Endows a Scaffold with Chemodynamic Therapy Properties. Journal of materials Science. 2023, 58(3): 1214 - 1228. (IF: 4.5)（彭淑平组）
70. He Z, Yue C, Chen X, Li X, Zhang L, Tan S, Yi X, Luo G, Zhou Y*. Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer. J Cancer. 2023 Jan 1;14(1):72 - 87. (IF: 4.478)（周艳宏组）
71. Peng Y, Ouyang L, Zhou Y, Lai W, Chen Y, Wang Z, Yan B, Zhang Z, Zhou Y, Peng X, Chen J, Peng X, Xiao D, Liu S, Tao Y, Liu W*. AhR Promotes the Development of Non - small cell lung cancer by Inducing SLC7A11 - dependent Antioxidant Function. J Cancer. 2023 Mar 27;14(5):821 - 834. (IF: 3.9)（陶永光组）
72. Zhang M, Peng S*. The association and clinical relevance of phase-separating protein CAPRIN1 with noncoding RNA. Cell Stress and Chaperones. 2023 Mar;28(2):125-132. (IF: 3.8)（彭淑平组）
73. Zheng L, Li M, Wei J, Chen S, Xue C, Duan Y, Tang F, Li G, Xiong W, She K, Deng H, Zhou M*. NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity. PLoS One. 2023 Sep 28;18(9):e0292212. (IF: 3.7)（周鸣组）
74. Liu X, Jiang B, Cheng A, Guo Y, Wang L, Liu W, Yin W, Li Y, Jiang X, Ren C*. The effects of doxorubicin loaded aptamer S3 - linked DNA tetrahedrons on nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg. 2023 Dec 12;52(1):79. (IF: 3.400)（任彩萍组）
75. Yan B, Xie B, Huang M, Guo J, Sun J, Chen J, Tao Y, Xiao D*. Mutations and expressions of breast cancer 1/2 in lung cancer. Thorac Cancer. 2023 Jun;14(18):1753 - 1763. (IF: 2.9)（陶永光组）
